Drugs / Ga-HBED-iPSMA
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT03204123 Comparator | Jun 2017 → Jun 2027 expected | prostate adenocarcinoma | Memorial Sloan Kettering Cancer Center | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ga-HBED-iPSMA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03204123 ↗ |